Abstract
Previous studies have shown that certain vaccines induce suboptimal responses in people living with human immunodeficiency virus (HIV, PLWH). However, responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines have not been fully characterized in these patients. Here we show that the BNT162b2 vaccine induces robust immune responses comparable to responses in healthy donors.
Original language | English (US) |
---|---|
Pages (from-to) | 1268-1270 |
Number of pages | 3 |
Journal | Clinical Infectious Diseases |
Volume | 74 |
Issue number | 7 |
DOIs | |
State | Published - Apr 1 2022 |
Keywords
- COVID
- PLWH
- SARS-CoV-2
- mRNA vaccine
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases